Akebia Therapeutics Inc. (AKBA)
NASDAQ: AKBA
· Real-Time Price · USD
3.24
-0.05 (-1.52%)
At close: Aug 15, 2025, 3:59 PM
3.25
0.31%
After-hours: Aug 15, 2025, 07:55 PM EDT
Akebia Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | 18.49 | -4.56 | -3.46 | -6.07 | -4.64 | 95.88 | -3.7 | -3.83 | -1.55 | -3.03 | -0.26 | 0.55 | -0.49 | -1.4 | -2.1 | -1.84 | -1.87 |
PEG Ratio | -0.15 | -0.3 | -0.03 | 0.11 | 0.00 | -0.92 | -0.13 | 0.11 | -0.02 | 0.04 | 0.00 | -0.00 | 0.06 | -0.08 | 0.06 | -0.14 | 0.07 |
PS Ratio | 7.89 | 8.94 | 7.42 | 4.78 | 10.25 | 4.19 | 5.11 | 3.03 | 2.58 | 1.92 | 1.19 | 0.51 | 2.09 | 6.62 | 10.27 | 11.56 | 9.97 |
PB Ratio | 18.39 | -8.45 | -5.51 | -6.18 | -12.26 | -7.7 | -5.45 | -6.38 | -7.21 | 11.36 | 4.19 | 1.04 | 4.94 | 5.16 | 3.65 | 3.50 | 2.44 |
P/FCF Ratio | -33.23 | -93 | -41.65 | -20.66 | -17.19 | -102.03 | -29.95 | 47.10 | -5.9 | -1.94 | 1.72 | -2.11 | -5.93 | -6.28 | -8.89 | -9.68 | -7.36 |
P/OCF Ratio | -33.28 | -93.04 | -41.47 | -20.72 | -17.19 | -102.03 | -29.95 | 47.10 | -5.9 | -1.94 | 1.72 | -2.11 | -5.96 | -6.28 | -8.89 | -9.68 | -7.37 |
OCF/S Ratio | -0.24 | -0.1 | -0.18 | -0.23 | -0.6 | -0.04 | -0.17 | 0.06 | -0.44 | -0.99 | 0.69 | -0.24 | -0.35 | -1.05 | -1.15 | -1.19 | -1.35 |
Debt / Equity Ratio | 2.20 | -0.97 | -0.96 | -3.1 | -3.61 | -3.41 | -1.46 | -2.19 | -5.77 | 10.68 | 7.28 | 2.16 | 5.18 | 1.78 | 0.90 | 0.71 | 0.59 |
Quick Ratio | 2.02 | 1.21 | 1.21 | 0.82 | 1.31 | 1.03 | 1.14 | 1.06 | 1.21 | 1.31 | 1.05 | 1.15 | 1.04 | 0.91 | 1.57 | 1.77 | 1.85 |
Current Ratio | 2.23 | 1.41 | 1.52 | 1.04 | 1.70 | 1.18 | 1.38 | 1.28 | 1.46 | 1.48 | 1.26 | 1.30 | 1.19 | 1.06 | 1.74 | 2.00 | 2.11 |
Asset Turnover | 0.18 | 0.21 | 0.18 | 0.20 | 0.14 | 0.23 | 0.18 | 0.22 | 0.14 | 0.16 | 0.11 | 0.24 | 0.12 | 0.11 | 0.08 | 0.09 | 0.08 |
Interest Coverage | -1.74 | -2.08 | -1.88 | -4.06 | -5.96 | 0.97 | -9.25 | -5.48 | -15.91 | -3.14 | -12.14 | 9.70 | -11.56 | -13.01 | -10.79 | -15.99 | -13.51 |
Return on Equity | 0.25 | 0.46 | 0.40 | 0.25 | 0.66 | -0.02 | 0.37 | 0.42 | 1.17 | -0.94 | -4.02 | 0.47 | -2.54 | -0.92 | -0.43 | -0.48 | -0.33 |
Return on Assets | 0.02 | -0.1 | -0.1 | -0.04 | -0.08 | n/a | -0.06 | -0.04 | -0.06 | -0.02 | -0.13 | 0.06 | -0.12 | -0.13 | -0.1 | -0.14 | -0.11 |
Return on Invested Capital | 0.06 | -0.1 | -0.09 | -0.07 | -0.09 | 0.01 | -0.08 | -0.05 | -0.07 | -0.02 | -0.16 | 0.11 | -0.16 | -0.18 | -0.13 | -0.18 | -0.14 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.87 | 0.56 | 0.62 | 0.60 | 0.63 | 0.66 | 0.57 | 0.69 | 0.51 | 0.96 | 0.23 | 0.85 | 0.49 | 0.16 | 0.67 | 0.01 | 0.34 |
Net Profit Margin | 0.11 | -0.49 | -0.54 | -0.2 | -0.55 | 0.01 | -0.34 | -0.2 | -0.42 | -0.16 | -1.14 | 0.23 | -1.08 | -1.19 | -1.22 | -1.57 | -1.33 |
Pretax Profit Margin | 0.11 | -0.49 | -0.54 | -0.2 | -0.55 | 0.01 | -0.34 | -0.2 | -0.65 | -0.14 | -1.06 | 0.23 | -1.01 | -1.19 | -1.22 | -1.57 | -1.33 |
Operating Profit Margin | 0.24 | -0.31 | -0.33 | -0.2 | -0.46 | 0.02 | -0.31 | -0.16 | -0.62 | -0.09 | -0.98 | 0.39 | -0.95 | -1.11 | -1.13 | -1.5 | -1.24 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | 0.24 | -0.14 | -0.11 | 0.07 | -0.19 | 0.22 | -0.09 | -0.01 | -0.4 | -0.02 | -0.83 | 0.34 | -0.79 | -0.95 | -0.93 | -1.3 | -1.07 |